or
Bookmark and Share
Method of treating asthma using (S)-.alpha.-fluoromethyl-histidine and esters thereof
   
Document Number
US Patent 5030645
Issued Date
July 9, 1991
Link
Inventors
Map
Abstract
(S)-.alpha.-fluoromethylhistidine, a potent, selective, mechanism-based inhibitor of mammalian histidine carboxylase, the enzyme responsible for biosynthesis of histamine in mammals, is useful in the treatment of asthma.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
5
Comments:
no comments yet
Owner
Merck & Co., Inc. (Rahway, NJ)
Published
July 9, 1991
Application Number
07/597,653
Filed
October 15, 1990
US Classification
514/396  
Int'l Classification
A61K   31/415   (20060101)  
USPTO Field of Search
514/396  
Related Patents
5741807 - Histidine compositions and methods for treating or preventing infectious and non-infectious diarrheas - Owned by Cytos Pharmaceuticals, L.P. (Durham, NC)

A method of preventing or reducing fluid and electrolyte losses in mammalian subjects under the effect of a stimulus that directly or indirectly causes such losses, by administering a therapeutically effective amount of D-histidine, L-histidine, a racemic mixture thereof, a non-racemic mixture thereof, and pharmaceutically acceptable salts in conjunction with a carrier. In one embodiment the method is useful in reducing or preventing intestinal tract fluid secretions, and fluid and electrolyte losses associated with diarrhea arising from a number of causative agents, such as infectious diarrheas and non-infectious diarrheas. Various therapeutic regimes of histidine administration and formulation are embodied. Therapeutic compositions of histidine in combination with other medicaments, e.g., those that produce a diarrheal side-effect, are disclosed as another embodiment.

5658937 - Effective treatment modality for infectious diseases, pulmonary conditons and sequelae thereof - Owned by Cytos Pharmaceuticals LLC (Durham, NC)

A treatment modality for infectious diseases and pulmonary conditions that result from the inflammatory responses by tissues to infections by microorganisms, including but not limited to viruses, retroviruses, bacteria, or other microorganisms, or toxins that arise from microorganisms comprises administering an effective amount of histidine to the affected subject to combat the disease or the distress condition resulting therefrom.

7542802 - Methods of regenerating tissue in airways - Owned by Asthmatx, Inc. (Sunnyvale, CA)

This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.

7264002 - Methods of treating reversible obstructive pulmonary disease - Owned by Asthmatx, Inc. (Mountain View, CA)

This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.

7273055 - Methods of treating asthma - Owned by Asthmatx, Inc. (Mountain View, CA)

This relates to treating an asthmatic lung and more particularly, relates to advancing a treatment device into the lung and treating the lung with the device. This also includes additional steps of treating the airway wall, applying energy or heat to the airway wall in an asthmatic lung.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us